Longitudinal Effects of Glucose-Lowering Medications on β-Cell Responses and Insulin Sensitivity in Type 2 Diabetes: The GRADE Randomized Clinical Trial

Author:

Rasouli Neda1ORCID,Younes Naji2,Ghosh Alokananda2,Albu Jeanine3,Cohen Robert M.4,DeFronzo Ralph A.5ORCID,Diaz Elsa6,Sayyed Kassem Laure7,Luchsinger José A.8ORCID,McGill Janet B.9,Sivitz William I.10ORCID,Tamborlane William V.11ORCID,Utzschneider Kristina M.12ORCID,Kahn Steven E.12ORCID, ,Crandall J.P.,McKee M.D.,Behringer-Massera S.,Brown-Friday J.,Xhori E.,Ballentine-Cargill K.,Duran S.,Estrella H.,Gonzalez de la torre S.,Lukin J.,Phillips L.S.,Burgess E.,Olson D.,Rhee M.,Wilson P.,Raines T.S.,Boers J.,Costello J.,Maher-Albertelli M.,Mungara R.,Savoye L.,White C.A.,Gullett C.,Holloway L.,Morehead F.,Person S.,Sibymon M.,Tanukonda S.,Adams C.,Ross A.,Balasubramanyam A.,Gaba R.,Gonzalez Hattery E.,Ideozu A.,Jimenez J.,Montes G.,Wright C.,Hollander P.,Roe E.,Jackson A.,Smiley A.,Burt P.,Estrada L.,Chionh K.,Ismail-Beigi F.,Falck-Ytter C.,Sayyed Kassem L.,Sood A.,Tiktin M.,Kulow T.,Newman C.,Stancil K.A.,Cramer B.,Iacoboni J.,Kononets M.V.,Sanders C.,Tucker L.,Werner A.,Maxwell A.,McPhee G.,Patel C.,Colosimo L.,Krol A.,Goland R.,Pring J.,Alfano L.,Kringas P.,Hausheer C.,Tejada J.,Gumpel K.,Kirpitch A.,Schneier H.,Green J.B.,AbouAssi H.,Chatterjee R.,Feinglos M.N.,English Jones J.,Khan S.A.,Kimpel J.B.,Zimmer R.P.,Furst M.,Satterwhite B.M.,Thacker C.R.,Evans Kreider K.,Mariash C.N.,Mather K.J.,Ismail H.M.,Lteif A.,Mullen M.,Hamilton T.,Patel N.,Riera G.,Jackson M.,Pirics V.,Aguillar D.,Howard D.,Hurt S.,Bergenstal R.,Carlson A.,Martens T.,Johnson M.,Hill R.,Hyatt J.,Jensen C.,Madden M.,Martin D.,Willis H.,Konerza W.,Yang S.,Kleeberger K.,Passi R.,Fortmann S.,Herson M.,Mularski K.,Glauber H.,Prihoda J.,Ash B.,Carlson C.,Ramey P.A.,Schield E.,Torgrimson-Ojerio B.,Arnold K.,Kauffman B.,Panos E.,Sahnow S.,Bays K.,Berame K.,Cook J.,Ghioni D.,Gluth J.,Schell K.,Criscola J.,Friason C.,Jones S.,Nazarov S.,Barzilay J.,Rassouli N.,Puttnam R.,Ojoawo B.,Nelson R.,Curtis M.,Hollis B.,Sanders-Jones C.,Stokes K.,El-Haqq Z.,Kolli A.,Tran T.,Wexler D.,Larkin M.E.,Meigs J.,Chambers B.,Dushkin A.,Rocchio G.,Yepes M.,Steiner B.,Dulin H.,Cayford M.,Chu K.,DeManbey A.,Hillard M.,Martin K.,Thangthaeng N.,Gurry L.,Kochis R.,Raymond E.,Ripley V.,Stevens C.,Park J.,Aroda V.,Ghazi A.,Magee M.,Ressing A.,Loveland A.,Hamm M.,Hurtado M.,Kuhn A.,Leger J.,Manandhar L.,Mwicigi F.,Sanchez O.,Young T.,Garg R.,Lagari-Libhaber V.,Florez H.J.,Valencia W.M.,Marks J.,Casula S.,Oropesa-Gonzalez L.,Hue L.,Cuadot A.,Nieto-Martinez R.,Riccio Veliz A.K.,Gutt M.,Kendal Y.J.,Veciana B.,Ahmann A.,Aby-Daniel D.,Joarder F.,Morimoto V.,Sprague C.,Yamashita D.,Cady N.,Rivera-Eschright N.,Kirchhoff P.,Morales Gomez B.,Adducci J.,Goncharova A.,Hox S.H.,Petrovitch H.,Matwichyna M.,Jenkins V.,Broadwater L.,Ishii R.R.,Bermudez N.O.,Hsia D.S.,Cefalu W.T.,Greenway F.L.,Waguespack C.,King E.,Fry G.,Dragg A.,Gildersleeve B.,Arceneaux J.,Haynes N.,Thomassie A.,Pavlionis M.,Bourgeois B.,Hazlett C.,Mudaliar S.,Henry R.,Boeder S.,Pettus J.,Diaz E.,Garcia-Acosta D.,Maggs S.,DeLue C.,Stallings A.,Castro E.,Hernandez S.,Krakoff J.,Curtis J.M.,Killean T.,Khalid M.,Joshevama E.,Diaz E.,Martin D.,Tsingine K.,Karshner T.,Albu J.,Pi-Sunyer F.X.,Frances S.,Maggio C.,Ellis E.,Bastawrose J.,Gong X.,Banerji M.A.,August P.,Lee M.,Lorber D.,Brown N.M.,Josephson D.H.,Thomas L.L.,Tsovian M.,Cherian A.,Jacobson M.H.,Mishko M.M.,Kirkman M.S.,Buse J.B.,Diner J.,Dostou J.,Machineni S.,Young L.,Bergamo K.,Goley A.,Kerr J.,Largay J.F.,Guarda S.,Cuffee J.,Culmer D.,Fraser R.,Almeida H.,Coffer S.,Debnam E.,Kiker L.,Morton S.,Josey K.,Fuller G.,Garvey W.T.,Cherrington A.L.,Dyer D.,Lawson M.C.R.,Griffith O.,Agne A.,McCullars S.,Cohen R.M.,Craig J.,Rogge M.C.,Burton K.,Kersey K.,Wilson C.,Lipp S.,Vonder Meulen M.B.,Adkins C.,Onadeko T.,Rasouli N.,Baker C.,Schroeder E.,Razzaghi M.,Lyon C.,Penaloza R.,Underkofler C.,Lorch R.,Douglass S.,Steiner S.,Sivitz W.I.,Cline E.,Knosp L.K.,McConnell J.,Lowe T.,Herman W.H.,Pop-Busui R.,Tan M.H.,Martin C.,Waltje A.,Katona A.,Goodhall L.,Eggleston R.,Kuo S.,Bojescu S.,Bule S.,Kessler N.,LaSalle E.,Whitley K.,Seaquist E.R.,Bantle A.,Harindhanavudhi T.,Kumar A.,Redmon B.,Bantle J.,Coe M.,Mech M.,Taddese A.,Lesne K.,Smith S.,Desouza C.,Kuechenmeister L.,Shivaswamy V.,Burbach S.,Rodriguez M.G.,Seipel K.,Alfred A.,Morales A.L.,Eggert J.,Lord G.,Taylor W.,Tillson R.,Schade D.S.,Adolphe A.,Burge M.,Duran-Valdez E.,Martinez J.,Bancroft A.,Kunkel S.,Ali Jamaleddin Ahmad F.,Hernandez McGinnis D.,Pucchetti B.,Scripsick E.,Zamorano A.,DeFronzo R.A.,Cersosimo E.,Abdul-Ghani M.,Triplitt C.,Juarez D.,Mullen M.,Garza R.I.,Verastiqui H.,Wright K.,Puckett C.,Raskin P.,Rhee C.,Abraham S.,Jordan L.F.,Sao S.,Morton L.,Smith O.,Osornio Walker L.,Schnurr-Breen L.,Ayala R.,Kreymer R.B.,Sturgess D.,Utzschneider K.M.,Kahn S.E.,Alarcon-Casas Wright L.,Boyko E.J.,Tsai E.C.,Trence D.L.,Trikudanathan S.,Fattaleh B.N.,Montgomery B.K.,Atkinson K.M.,Kozedub A.,Concepcion T.,Moak C.,Prikhodko N.,Rhothisen S.,Elasy T.A.,Martin S.,Shackelford L.,Goidel R.,Hinkle N.,Lovell C.,Myers J.,Lipps Hogan J.,McGill J.B.,Salam M.,Schweiger T.,Kissel S.,Recklein C.,Clifton M.J.,Tamborlane W.,Camp A.,Gulanski B.,Inzucchi S.E.,Pham K.,Alguard M.,Gatcomb P.,Lessard K.,Perez M.,Iannone L.,Magenheimer E.,Montosa A.,Fradkin J.,Burch H.B.,Bremer A.A.,Nathan D.M.,Lachin J.M.,Krause-Steinrauf H.,Younes N.,Bebu I.,Butera N.,Buys C.J.,Fagan A.,Gao Y.,Ghosh A.,Gramzinski M.R.,Hall S.D.,Kazemi E.,Legowski E.,Liu H.,Suratt C.,Tripputi M.,Arey A.,Backman M.,Bethepu J.,Lund C.,Mangat Dhaliwal P.,McGee P.,Mesimer E.,Ngo L.,Steffes M.,Seegmiller J.,Saenger A.,Arends V.,Gabrielson D.,Conner T.,Warren S.,Day J.,Huminik J.,Scrymgeour A.,Soliman E.Z.,Pokharel Y.,Zhang Z.M.,Campbell C.,Hu J.,Keasler L.,Hensley S.,Li Y.,Mihalcea R.,Min D.J.,Perez-Rosas V.,Prosser L.,Resnicow L.,Ye W.,Shao H.,Zhang P.,Luchsinger J.,Sanchez D.,Assuras S.,Groessl E.,Sakha F.,Chong H.,Hillery N.,Abdouch I.,Bahtiyar G.,Brantley P.,Broyles F.E.,Canaris G.,Copeland P.,Craine J.J.,Fein W.L.,Gliwa A.,Hope L.,Lee M.S.,Meiners R.,Meiners V.,O’Neal H.,Park J.E.,Sacerdote A.,Sledge E.,Soni L.,Steppel-Reznik J.,Turchin A.

Affiliation:

1. 1Division of Endocrinology, Metabolism and Diabetes, Department of Medicine, University of Colorado School of Medicine, and VA Eastern Colorado Health Care System, Aurora, CO

2. 2The Biostatistics Center, Department of Biostatistics and Bioinformatics, Milken Institute School of Public Health, The George Washington University, Rockville, MD

3. 3Icahn School of Medicine, Mount Sinai Morningside, New York, NY

4. 4Division of Endocrinology, Diabetes and Metabolism, University of Cincinnati College of Medicine and Cincinnati VA Medical Center, Cincinnati, OH

5. 5University of Texas Health Science Center, San Antonio, TX

6. 6VA San Diego Healthcare System, San Diego, CA

7. 7Department of Endocrinology, Louis Stokes Cleveland Department of Veterans Affairs Medical Center, Cleveland, OH

8. 8Departments of Medicine and Epidemiology, Columbia University Irving Medical Center, New York, NY

9. 9Division of Endocrinology, Metabolism and Lipid Research, Washington University School of Medicine, St. Louis, MO

10. 10Department of Internal Medicine, University of Iowa, Iowa City, IA

11. 11Yale School of Medicine, New Haven, CT

12. 12Division of Metabolism, Endocrinology and Nutrition, Department of Medicine, VA Puget Sound Health Care System and University of Washington, Seattle

Abstract

OBJECTIVE To compare the long-term effects of glucose-lowering medications (insulin glargine U-100, glimepiride, liraglutide, and sitagliptin) when added to metformin on insulin sensitivity and β-cell function. RESEARCH DESIGN AND METHODS In the Glycemia Reduction Approaches in Diabetes: A Comparative Effectiveness Study (GRADE) cohort with type 2 diabetes (n = 4,801), HOMA2 was used to estimate insulin sensitivity (HOMA2-%S) and fasting β-cell function (HOMA2-%B) at baseline and 1, 3, and 5 years on treatment. Oral glucose tolerance test β-cell responses (C-peptide index [CPI] and total C-peptide response [incremental C-peptide/incremental glucose over 120 min]) were evaluated at the same time points. These responses adjusted for HOMA2-%S in regression analysis provided estimates of β-cell function. RESULTS HOMA2-%S increased from baseline to year 1 with glargine and remained stable thereafter, while it did not change from baseline in the other treatment groups. HOMA2-%B and C-peptide responses were increased to variable degrees at year 1 in all groups but then declined progressively over time. At year 5, CPI was similar between liraglutide and sitagliptin, and higher for both than for glargine and glimepiride [0.80, 0.87, 0.74, and 0.64 (nmol/L)/(mg/dL) * 100, respectively; P < 0.001], while the total C-peptide response was greatest with liraglutide, followed in descending order by sitagliptin, glargine, and glimepiride [1.54, 1.25, 1.02, and 0.87 (nmol/L)/(mg/dL) * 100, respectively, P < 0.001]. After adjustment for HOMA2-%S to obtain an estimate of β-cell function, the nature of the change in β-cell responses reflected those in β-cell function. CONCLUSIONS The differential long-term effects on insulin sensitivity and β-cell function of four different glucose-lowering medications when added to metformin highlight the importance of the loss of β-cell function in the progression of type 2 diabetes.

Funder

National Institute of Diabetes and Digestive and Kidney Diseases

Centers for Disease Control and Prevention

The American Diabetes Association

The National Heart, Lung, and Blood Institute

Publisher

American Diabetes Association

Cited by 3 articles. 订阅此论文施引文献 订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号  京ICP备18003416号-3